A Manual of Clinical Psychopharmacologyby Alan F. Schatzberg, Jonathan O. Cole
Compatible with DSM-IV, this manual provides concise and updated guidance in the selection and prescription of appropriate drug therapies for individual patients. It reviews all classes of psychiatric medications, including new drugs such as olanzapine, sertindole, gabapentin, mirtazapine, and venlafaxine. Updated information on side effects and dosages is included. Special chapters address the pharmacotherapy of chemical dependence and abuse and emergency room treatment, as well as treatment recommendations for children, mentally retarded people, elderly people, and other special patient groups.
Doody's Health Sciences Book Review Journal).
Description: This eighth edition of a guide to psychotropic medications updates the 2010 edition, reflecting the diagnostic changes in the DSM-5 and recent research data.
Purpose: The authors continue to provide "a readable, up-to-date guide to clinical psychopharmacology," an extremely important objective given the continually expanding number of psychotropic agents available. The authors excel at achieving their objective.
Audience: The authors indicate their target audience is psychiatrists who prescribe medications and students in psychiatry. Because it is so practical, the book can be used by the identified audience as well as other healthcare providers (PAs, NPs, PCPs).
Features: The book begins with the foundation of the general principles of psychopharmacological treatment and reviews the changes in the DSM-5. The next six chapters examine the common categories of psychiatric medications including antipsychotics, stimulants, and antidepressants, among others. The final four chapters review augmentation strategies and the different treatment considerations in different settings and populations such as the emergency department, children, and for substance abuse. Each chapter has helpful graphics and ends with a bibliography. An appendix with recommended reading options and a helpful index conclude the manual. It would be more convenient to place the recommended readings in the relevant sections that reference them instead of grouping them together at the end of the book.
Assessment: As a resident psychiatrist, one of my attending psychiatrists suggested I use this book in my training. I continue to rely on it because of its superior quality as a clinically practical and useful resource. Readers can open the book to a desired section and quickly educate themselves on a particular topic related to common psychiatric medications in a much more efficient and data-driven way than any by using other books or websites. Because the authors rightly strive to keep this manual a reasonable size, some readers may need to turn to other resources to learn about psychotropic medications that are not as commonly used.
- American Psychiatric Publishing, Incorporated
- Publication date:
What People are Saying About This
This 8th edition, like earlier editions, is an outstanding resource for all who prescribe medications to individuals with psychiatric disorders or symptoms needing treatment. I recommend this 8th edition to all practitioners who may prescribe medications to these individuals; I also believe that this Manual will also be a useful resource for mental health clinicians who do not prescribe medications.
Meet the Author
Alan F. Schatzberg, M.D., is Kenneth T. Norris, Jr., Professor in the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine in Stanford, California.
Charles DeBattista, D.M.H., M.D., is Professor of Psychiatry and Behavioral Sciences, Director of the Depression Clinic and Research Program, and Director of Medical Student Education in Psychiatry in the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine in Stanford, California.
American Psychiatric Publishing
Most Helpful Customer Reviews
See all customer reviews